Anaptysbio Inc (ANAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2006 | 12-2005 | |
| Sales | 17,571 | 15,838 | 5,483 | 0 | 0 |
| Gross Profit | 17,571 | 15,838 | 5,483 | N/A | N/A |
| Operating Expenses | 20,893 | 10,968 | 10,770 | 0 | 0 |
| Operating Income | -3,322 | 4,870 | -5,287 | N/A | N/A |
| Interest Expense | 460 | 1,281 | 886 | 0 | 0 |
| Other Income | -1,484 | -57 | 6,173 | 0 | 0 |
| Pre-tax Income | -5,266 | 3,532 | 0 | 0 | 0 |
| Income Tax | 139 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -5,405 | 3,532 | -5,545 | N/A | N/A |
| Net Income | $-5,405 | $3,532 | $-5,545 | $N/A | $N/A |
| EPS Basic Total Ops | -2.12 | 0.09 | -0.71 | N/A | N/A |
| EPS Basic Continuous Ops | -2.12 | 1.42 | -0.71 | N/A | N/A |
| EPS Diluted Total Ops | -2.12 | 0.09 | -0.71 | N/A | N/A |
| EPS Diluted Continuous Ops | -2.12 | 1.42 | -0.71 | N/A | N/A |
| EBITDA(a) | $-3,048 | $5,178 | $-4,707 | $N/A | $N/A |